Literature DB >> 24842194

Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success.

Liam S Redgrave1, Sam B Sutton1, Mark A Webber1, Laura J V Piddock2.   

Abstract

Quinolone and fluoroquinolone antibiotics are potent, broad-spectrum agents commonly used to treat a range of infections. Resistance to these agents is multifactorial and can be via one or a combination of target-site gene mutations, increased production of multidrug-resistance (MDR) efflux pumps, modifying enzymes, and/or target-protection proteins. Fluoroquinolone-resistant clinical isolates of bacteria have emerged readily and recent data have shown that resistance to this class of antibiotics can have diverse, species-dependent impacts on host-strain fitness. Here we outline the impacts of quinolone-resistance mutations in relation to the fitness and evolutionary success of mutant strains.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  chromosome structure; fitness

Mesh:

Substances:

Year:  2014        PMID: 24842194     DOI: 10.1016/j.tim.2014.04.007

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  188 in total

1.  Genome-wide discovery of epistatic loci affecting antibiotic resistance in Neisseria gonorrhoeae using evolutionary couplings.

Authors:  Benjamin Schubert; Rohan Maddamsetti; Jackson Nyman; Maha R Farhat; Debora S Marks
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

2.  Effects of Stress, Reactive Oxygen Species, and the SOS Response on De Novo Acquisition of Antibiotic Resistance in Escherichia coli.

Authors:  Nadine Händel; Marloes Hoeksema; Marina Freijo Mata; Stanley Brul; Benno H ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

3.  Global DNA Methylation Level among Ciprofloxacin-Resistant Clinical Isolates of Escherichia coli.

Authors:  Thiyagarajan Yugendran; Belgode Narasimha Harish
Journal:  J Clin Diagn Res       Date:  2016-05-01

4.  Resistance and Virulence Mechanisms of Escherichia coli Selected by Enrofloxacin in Chicken.

Authors:  Jun Li; Haihong Hao; Menghong Dai; Heying Zhang; Jianan Ning; Guyue Cheng; Muhammad Abu Bakr Shabbir; Abdul Sajid; Zonghui Yuan
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

5.  Antibiotic treatment disrupts bacterial communities in the colon and rectum of simian immunodeficiency virus-infected macaques.

Authors:  Alexander S Zevin; Tiffany Hensley-McBain; Charlene Miller; Elise Smith; Stanley Langevin; Nichole R Klatt
Journal:  FEMS Microbiol Lett       Date:  2017-12-15       Impact factor: 2.742

6.  A Roadblock-and-Kill Mechanism of Action Model for the DNA-Targeting Antibiotic Ciprofloxacin.

Authors:  Nikola Ojkic; Elin Lilja; Susana Direito; Angela Dawson; Rosalind J Allen; Bartlomiej Waclaw
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  Soft sweep development of resistance in Escherichia coli under fluoroquinolone stress.

Authors:  Xianxing Xie; Ruichen Lv; Chao Yang; Yajun Song; Yanfeng Yan; Yujun Cui; Ruifu Yang
Journal:  J Microbiol       Date:  2019-09-25       Impact factor: 3.422

Review 8.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

9.  Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria.

Authors:  Liam Berry; Ronald Domalaon; Marc Brizuela; George G Zhanel; Frank Schweizer
Journal:  Medchemcomm       Date:  2019-03-07       Impact factor: 3.597

10.  Prevalence of Quinolone Resistance in Enterobacteriaceae from Sierra Leone and the Detection of qnrB Pseudogenes and Modified LexA Binding Sites.

Authors:  Tomasz A Leski; Michael G Stockelman; Umaru Bangura; Daniel Chae; Rashid Ansumana; David A Stenger; Gary J Vora; Chris R Taitt
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.